Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
andrew.lewis@kellogg.ox.ac.uk

Telephone
01865 272560

Research groups

Tyler Group

Andrew Lewis

Clinical Lecturer

Based in the Radcliffe Department of Medicine (RDM)

Recent publications

Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction.

Zhang K. et al, (2026), Science, 391

Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy.

Anderson S. et al, (2026), Nat Cardiovasc Res, 5, 138 - 154

First-in-Human Study of the Carbohydrate Nanoparticle 64Cu-Macrin.

O'Shea A. et al, (2025), J Nucl Med

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.

Hundertmark MJ. et al, (2025), Circulation

Safety and Feasibility of Magnetic Resonance Imaging Within the First Week Following Transvenous Pacing System Implantation.

Raby J. et al, (2025), Circulation, 152, 1393 - 1395

More publications